Found 9 matching trials
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
UT MD Anderson Cancer Center
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
PHASE1The goal of this clinical research study is to find the recommended dose le...
Location
The University of Texas M. D. Anderson Cancer Center
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PHASE1Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive ...
Location
Moffitt Cancer Center
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PHASE1Phase I trial, unicentric, uncontrolled. Intratumoral injection or intramur...
Location
Clinica Universidad de Navarra
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PHASE2Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive ...
Location
University of Arkansas for Medical Sciences (UAMS)
Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas
PHASE1Oncolytic adenovirus for pediatric naive DIPG, to be infused after tumor bi...
Location
Clinica Universidad de Navarra
Combination Therapy for the Treatment of Diffuse Midline Gliomas
PHASE2This phase II trial determines if the combination of ONC201 with different ...
Location
University of Alabama at Birmingham
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
PHASE1This phase I trial studies best dose and side effects of oncolytic adenovir...
Location
M D Anderson Cancer Center
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
PHASE2The goal of this clinical trial is to learn if intratumoral administration ...
Location
Princess Máxima Centrum